Also in this newsletter: How greener corporate car fleets could boost competitiveness and the climate goals
US biotech researches treatments to reduce muscle loss from blockbuster diet medicines
Unsightly kerbside debris to some, eco-friendly cycles for hire have improved urban journeys
Weight loss drugs appear to be having an effect at the population level
From a Maldives villa with skateboard ramps, zip lines and bowling alley to an East Sussex barn conversion with a treetop play area
International collaboration plotted 149 metres of biological wiring in fruit fly
The company is thriving as weight-loss drugs boom, but investors see warning signs it has reached ‘peak enthusiasm’
Weight-loss drugs and a new focus on wellness are pushing many exercise machines towards obsolescence
New York City appointed a ‘rat tsar’ and launched ‘rat academies’ — its inaugural National Urban Rat Summit aimed to offer fresh insights to help landlords and renters
Artificial intelligence used to help researchers plan experiments and better predict outcomes
Drugmaker’s CEO sees chance to widen use of anti-obesity medications for ‘health maintenance’
Swiss pharma group is a high spender on R&D but has had misses in Alzheimer’s and cancer
Mandatory reporting and clear road map of reform needed, say retail giants and financial groups
From playlists to pressure washers, the internet’s vacant spaces can be refuges in the too-much-information age
The fashion world is embracing weight-loss drugs — discreetly
Claudia Donaldson assumed a months-long rest cure would bore her senseless. Instead, she found it transformational
The next stage in the war on cancer may be enlisting patients’ own blood cells to fight the disease
Data shows increasing numbers in rich countries turning to welfare
The reduced effectiveness of antibiotics risks severe disruption to the global economy
The lessons learnt from drug-resistant tuberculosis offer a path to beating back the ‘silent pandemic’ of antimicrobial resistance
Post-Brexit overhaul of alcohol duty and shifting lifestyles fuel boom in low-ABV drinks
Sexologist and intimacy coach Michaela d’Artois wants to show you the way
Emmanuel Hanon criticises former company’s drug after he raises $100mn for rival product
Gavi chief Sania Nishtar offers rich nations long-term payment options for life-saving jabs
Lack of appointments blamed for fall in take-up of key vaccinations
